News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,988 Results
Type
Article (87305)
Company Profile (759)
Press Release (770897)
Multimedia
Podcasts (166)
Webinars (27)
Section
Business (232999)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91222)
Employer Resources (202)
FDA (18262)
Job Trends (17392)
News (397267)
Policy (39910)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (122)
Alliances (56979)
ALS (139)
Alzheimer's disease (1661)
Antibody-drug conjugate (ADC) (211)
Approvals (18266)
Artificial intelligence (466)
Autoimmune disease (52)
Automation (24)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (155)
Biotechnology (484)
Bladder cancer (120)
Brain cancer (47)
Breast cancer (454)
Cancer (3640)
Cardiovascular disease (322)
Career advice (3551)
Career pathing (36)
CAR-T (236)
CDC (52)
Cell therapy (644)
Cervical cancer (31)
Clinical research (75070)
Collaboration (1317)
Company closure (4)
Compensation (876)
Complete response letters (57)
COVID-19 (2946)
CRISPR (80)
C-suite (522)
Cystic fibrosis (130)
Data (3964)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (438)
Diagnostics (7067)
Digital health (31)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (225)
Drug pricing (171)
Drug shortages (36)
Duchenne muscular dystrophy (188)
Earnings (98661)
Editorial (53)
Employer branding (25)
Employer resources (171)
Events (132541)
Executive appointments (961)
FDA (20568)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1171)
Gene editing (167)
Generative AI (45)
Gene therapy (510)
GLP-1 (1005)
Government (5359)
Grass and pollen (7)
Guidances (334)
Healthcare (20937)
HIV (48)
Huntington's disease (35)
IgA nephropathy (54)
Immunology and inflammation (232)
Immuno-oncology (19)
Indications (50)
Infectious disease (3171)
Inflammatory bowel disease (180)
Inflation Reduction Act (14)
Influenza (89)
Intellectual property (175)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (630)
Leadership (31)
Legal (10147)
Liver cancer (91)
Longevity (12)
Lung cancer (519)
Lymphoma (252)
Machine learning (25)
Management (66)
Manufacturing (593)
MASH (125)
Medical device (14842)
Medtech (14860)
Mergers & acquisitions (22695)
Metabolic disorders (1111)
Multiple sclerosis (131)
NASH (23)
Neurodegenerative disease (201)
Neuropsychiatric disorders (53)
Neuroscience (2614)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (549)
Opinion (305)
Ovarian cancer (122)
Pain (157)
Pancreatic cancer (156)
Parkinson's disease (223)
Partnered (28)
Patents (395)
Patient recruitment (279)
Peanut (57)
People (66109)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23141)
Phase II (32605)
Phase III (24532)
Pipeline (2549)
Policy (285)
Postmarket research (3554)
Preclinical (10449)
Press Release (72)
Prostate cancer (183)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (627)
Real estate (7418)
Recruiting (78)
Regulatory (27804)
Reports (64)
Research institute (2680)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (67)
Schizophrenia (123)
Series A (194)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (97)
Tariffs (85)
The Weekly (105)
Vaccines (1020)
Venture capital (64)
Weight loss (384)
Women's health (57)
Worklife (21)
Date
Today (56)
Last 7 days (509)
Last 30 days (2293)
Last 365 days (33739)
2025 (24527)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50849)
Australia (8932)
California (9062)
Canada (2763)
China (859)
Colorado (383)
Connecticut (405)
Delaware (249)
Europe (116811)
Florida (1334)
Georgia (306)
Hawaii (3)
Idaho (67)
Illinois (793)
India (47)
Indiana (445)
Iowa (19)
Japan (286)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (75)
Maryland (1230)
Massachusetts (6813)
Michigan (302)
Minnesota (549)
Mississippi (4)
Missouri (114)
Montana (33)
Nebraska (26)
Nevada (105)
New Hampshire (76)
New Jersey (2508)
New Mexico (32)
New York (2474)
North Carolina (1376)
North Dakota (10)
Northern California (4043)
Ohio (285)
Oklahoma (19)
Oregon (50)
Pennsylvania (1889)
Puerto Rico (19)
Rhode Island (45)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3457)
Tennessee (145)
Texas (1414)
United States (33604)
Utah (270)
Virginia (240)
Washington D.C. (82)
Washington State (783)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 858,988 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
September 29, 2025
·
6 min read
Press Releases
Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
September 29, 2025
·
4 min read
Press Releases
Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
September 29, 2025
·
5 min read
Press Releases
Pooled data presented at ERS: nerandomilast monotherapy linked to nominally significant reduction in risk of death in IPF and PPF
September 29, 2025
·
8 min read
Press Releases
Angle PLC Announces Presentation of Data on Glioblastoma
September 29, 2025
·
5 min read
Press Releases
Astellas Announces Top Management Personnel Change
September 29, 2025
·
2 min read
Press Releases
Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update
September 29, 2025
·
19 min read
Press Releases
Virometix Announces Completion of Enrollment in Phase I Trial of V-212 — a Fully Synthetic, Serotype-Independent Vaccine Candidate Against Streptococcus Pneumoniae
September 29, 2025
·
3 min read
Press Releases
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
September 29, 2025
·
15 min read
Press Releases
Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2025
September 29, 2025
·
7 min read
1 of 85,899
Next
